Literature DB >> 7593778

Histologic features of congenital melanocytic nevi in infants 1 year of age or younger.

R L Barnhill1, M Fleischli.   

Abstract

BACKGROUND: Congenital melanocytic nevi (CMN) occur in approximately 1% of the white population. These lesions are often surgically excised prophylactically because of increased melanoma risk.
OBJECTIVE: In this study 87 CMN of all sizes from infants 12 months of age or younger (mean age, 6.6 months) were examined histologically.
METHODS: Each lesion was evaluated for depth of nevus cell involvement, overall epidermal and dermal pattern, and cytologic atypia.
RESULTS: Most CMN involved the lower half of the reticular dermis (89%), and 51% infiltrated the subcutaneous tissue. Depth of nevus cell infiltration was positively correlated with size of the lesion. The predominant dermal pattern was diffuse interstitial infiltration (63%). Patchy nevus cell patterns were observed in 37% of the CMN and were associated with smaller lesions (p < 0.001). Most of the CMN displayed no cytologic atypia (70%), and we found no cases of melanoma. Atypia was not significantly associated with either size or location of the nevus.
CONCLUSION: These results indicate that depth and pattern of nevus cells are directly related to size of CMN in infants.

Entities:  

Mesh:

Year:  1995        PMID: 7593778     DOI: 10.1016/0190-9622(95)91816-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  [Therapy of congenital melanocytic nevi. Excision, dermabrasion, laser].

Authors:  B Konz
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

Review 2.  Biologically distinct subsets of nevi.

Authors:  Tova Rogers; Maria L Marino; Patricia Raciti; Manu Jain; Klaus J Busam; Michael A Marchetti; Ashfaq A Marghoob
Journal:  G Ital Dermatol Venereol       Date:  2016-04-27       Impact factor: 2.011

Review 3.  Giant congenital melanocytic nevus.

Authors:  Ana Carolina Leite Viana; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.